Sotac Pharmaceuticals Ltd share price logo

Sotac Pharmaceuticals Ltd (SOTAC)

₹1693.98%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Performance

  • Day's High

    ₹169
    ₹182
  • 52 Week's Low

    52 Week's High

    ₹87.1
    ₹184
1 Month Return+ 44.26 %
3 Month Return+ 44.26 %
1 Year Return+ 49.15 %
Previous Close₹176.00
Open₹182.00
Volume4,800.00
Upper Circuit-
Lower Circuit-
Market Cap₹194.48Cr

Key Statistics

P/E Ratio46.19
PEG Ratio-9.62
Market Cap₹194.48 Cr
P/B Ratio0
EPS0

Company Information

Sotac Pharmaceuticals Limited is a part of the Gujarat based SOTAC Group, offering a range of products such as tablets, capsules, oral liquids, and external preparations. Their therapeutic portfolio includes options for treating ailments such as diabetes, psychotics, vitamins, minerals, cold, allergies, ulcers, and more. They started off as a Partnership Firm in October 2015 and have since then evolved into a Public Limited Company. Their installed capacity for manufacturing is 90 crore tables and 14 crore capsules per year. In 2022, they acquired two subsidiary companies and started a new venture called SOTAC Lifescience Private Limited, raising 51 percent of total paid-up capital. They are planning to come out with a Initial Public Offer consisting of up to 3 million equity shares through a fresh issue.

Share Price: ₹169.00 per share as on 11 Jul, 2024 04:01 PM
Market Capitalisation: ₹194.48Cr as of today
Revenue: ₹26.45Cr as on March 2024 (Q1 24)
Net Profit: ₹1.51Cr as on March 2024 (Q1 24)
Listing date: 13 Apr, 2023
Chairperson Name: Sharadkumar Dashrathbhai Patel
OrganisationSotac Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sotac Pharmaceuticals Ltd

  • Sotac Pharmaceuticals' High P/E Ratio Raises Concerns - 28 Jun, 2024

    Sotac Pharmaceuticals has a high P/E ratio of 39.7x, which may be unjustified despite strong recent earnings growth of 37%. Shareholders may face disappointment if the P/E falls to levels more in line with recent growth rates.

  • Sotac Pharmaceuticals Receives Order Worth Rs. 17.13 Crores - 26 Jun, 2024

    Shares of Sotac Pharmaceuticals surged by 20% after receiving an order worth Rs. 17.13 crores from Rajasthan Medical Services Corporation Limited. The company's revenue increased by 35% and net profits magnified by 100% in FY23-24. Key customers include Cadila Pharma, Intas Pharma, and Eris Lifesciences. Promoters hold a stake of 72.85%, while FIIs hold 8.99% of the shares.

  • Sotac Pharmaceuticals' Financial Prospects Look Decent Despite Recent Stock Weakness - 05 Jun, 2024

    Despite Sotac Pharmaceuticals' stock being down 33% over the past three months, its key financial indicators look decent. The company's ROE suggests that the stock could potentially rise in the long-term given more resilient long-term fundamentals.

Insights on Sotac Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.65 Cr → 1.64 Cr (in ₹), with an average increase of 36.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SOTAC stock has moved up by 25.7%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.51% to 8.99% in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.85% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 18.64% to 18.16% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 26.73 Cr → 26.26 Cr (in ₹), with an average decrease of 0.9% per quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹26.45Cr
↑2.76%
Net Income
₹1.51Cr
↑71.59%
Net Profit Margin
5.71%
↑66.96%
2023Y/Y Change
Revenue
₹77.48Cr
↑58.64%
Net Income
₹2.29Cr
↓196.62%
Net Profit Margin
2.96%
↓161.03%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹54.95Cr
↑51.21%
Total Liabilities
₹33.96Cr
↑16.14%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹8.54Cr
↑138.55%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
72.85%
0.00
Foreign Institutions
8.99%
0.00
Mutual Funds
0%
0.00
Retail Investors
18.16%
0.00
Others
0%
0.00

Key Indicators

Sotac Pharmaceuticals Ltd Valuation

Sotac Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (13.14x)

April 24, 2023

Today (46.19x)

July 10, 2024

Industry (62.76x)

July 10, 2024

Highest (47.24x)

July 9, 2024

LowHigh

Earnings and Dividends

  • Sotac Pharmaceuticals Ltd Earnings Results

    Sotac Pharmaceuticals Ltd’s net profit jumped 57.69% since last year same period to ₹1.64Cr in the Q4 2023-2024. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated 82.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Sotac Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sotac Pharmaceuticals Ltd shares.

Sotac Pharmaceuticals Ltd (SOTAC) share price today is ₹169

Sotac Pharmaceuticals Ltd is listed on NSE

Sotac Pharmaceuticals Ltd is not listed on BSE

  • Today’s highest price of Sotac Pharmaceuticals Ltd is ₹182.
  • Today’s lowest price of Sotac Pharmaceuticals Ltd is ₹169.

PE Ratio of Sotac Pharmaceuticals Ltd is 46.19

PE ratio = Sotac Pharmaceuticals Ltd Market price per share / Sotac Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Sotac Pharmaceuticals Ltd(SOTAC) is 4,800.00.

Today’s market capitalisation of Sotac Pharmaceuticals Ltd(SOTAC) is ₹194.48Cr.

Sotac Pharmaceuticals Ltd(SOTACPrice
52 Week High
₹184
52 Week Low
₹87.1

Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹169. It is down -8.15% from its 52 Week High price of ₹184

Sotac Pharmaceuticals Ltd(SOTAC) share price is ₹169. It is up 94.03% from its 52 Week Low price of ₹87.1

Sotac Pharmaceuticals Ltd(SOTACReturns
1 Day Returns
-7%
1 Month Returns
44.26%
3 Month Returns
44.26%
1 Year Returns
49.15%